Synopsis: 2005 Annual Meeting of the American Society of Andrology

    November 2005 in “ Journal of Andrology ”
    Janice L. Bailey, Janice P. Evans, Matt Hardy, John C. Herr, Kate L. Loveland, Alvin M. Matsumoto, Jacquetta M. Trasler, Paul J. Turek, Monica Vasquez‐Levin, Christina Wang
    TLDR The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.
    The 2005 Annual Meeting of the American Society of Andrology highlighted advancements in male reproductive biology, focusing on genetic and biochemical interventions for fertility and erectile dysfunction. Key discussions included gene therapy for erectile dysfunction, with promising results from endothelial nitric oxide synthase (eNOS) in rodent models, and the potential of mesenchymal stem cells. Prostate cancer research revealed finasteride's effect on low-grade cancer and concerns about high-grade cancer. The meeting also addressed male contraception, chronic prostatitis, and the safety of Intracytoplasmic Sperm Injection (ICSI), noting increased congenital malformations in ICSI offspring. Overall, the meeting underscored the complexity of male fertility and the need for further research into genetic causes and treatment outcomes.
    Discuss this study in the Community →